High Iron Level in KRAS Cancer Cells Can Help Target Treatment
Researchers have successfully used an FDA-approved drug to stop the growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed